Emerging Systemic Therapies in Advanced Unresectable Biliary Tract Cancer: Review and Canadian Perspective †

Biliary tract cancer (BTC) is a group of rare and aggressive malignancies with a dismal prognosis. There is currently a significant lack in effective treatment options for BTC, with gemcitabine-cisplatin remaining the first-line standard of care treatment for over a decade. A wave of investigational...

Descripción completa

Detalles Bibliográficos
Autores principales: Tam, Vincent C., Ramjeesingh, Ravi, Burkes, Ronald, Yoshida, Eric M., Doucette, Sarah, Lim, Howard J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600578/
https://www.ncbi.nlm.nih.gov/pubmed/36290832
http://dx.doi.org/10.3390/curroncol29100555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600578/
https://www.ncbi.nlm.nih.gov/pubmed/36290832
http://dx.doi.org/10.3390/curroncol29100555

Ejemplares similares